Acetoacetyl-CoA Reductase Variant for Flexible High-3HB PHA Copolymers

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing polyhydroxyalkanoate (PHA) production methods struggle to produce 3-hydroxybutyrate-4-hydroxybutyrate copolymers with varying physical properties, limiting their applicability due to the brittleness and processability issues of 3-hydroxybutyrate homopolymers.

Innovation Solution

A protein variant with acetoacetyl-CoA reductase activity is developed, featuring specific amino acid substitutions at key positions, which is used to enhance PHA production in microorganisms, enabling high-yield production of 3-hydroxybutyrate-4-hydroxybutyrate copolymers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If 3-hydroxybutyrate homopolymer is produced, then high crystallinity and mechanical strength are achieved, but brittleness increases and processability deteriorates

Engineering Contradiction:
Improvemechanical strengthVSAvoidprocessability
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The patent produces copolymers comprising 3-hydroxybutyrate and 4-hydroxybutyrate monomers in a controlled ratio (3:2 to 4:1). This composite approach combines the high strength of 3HB homopolymer with the flexibility of 4HB, resolving the contradiction between mechanical strength and processability by creating a material that exhibits both properties simultaneously.

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If 4-hydroxybutyrate content is increased to improve flexibility, then processability is enhanced, but mechanical strength decreases

Engineering Contradiction:
ImproveflexibilityVSAvoidmechanical strength
Core Design Contradiction:
Ease of operationVSStrength

Solution Approach 1:

The patent precisely controls the monomer ratio parameter, maintaining 3HB at 60-80% and 4HB at 20-40%. This parameter optimization ensures the copolymer achieves both flexibility and mechanical strength, avoiding the strength loss that would occur with higher 4HB content while still improving processability compared to pure 3HB homopolymer.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If existing acetoacetyl-CoA reductase is used, then PHA production is achieved, but production yield is limited

Engineering Contradiction:
ImprovePHA production yieldVSAvoidcopolymer production amount
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent employs site-directed mutagenesis to modify the acetoacetyl-CoA reductase enzyme, specifically changing amino acid residues at positions 35, 36, and 37. These parameter changes in the enzyme's active site enhance its catalytic efficiency and substrate specificity, enabling higher conversion rates of acetoacetyl-CoA to 3-hydroxybutyryl-CoA, thereby increasing overall PHA production yield and copolymer synthesis efficiency.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The protein variant enhances PHA production, allowing for the creation of copolymers with a high 3-hydroxybutyrate content, improving the material's flexibility and processability.

Implementation Method 1

a protein variant with acetoacetyl-CoA reductase activity is developed, featuring specific amino acid substitutions at key positions

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP4726033A1Novel acetoacetyl-coa reductase variant and use thereof
Publication Date: 2026.04.15 CJ CHEILJEDANG CORP
  • EP4726033A1 patent drawing
  • EP4726033A1 patent drawing
  • EP4726033A1 patent drawing

AI summary

Provide are a novel protein having acetoacetyl-CoA reductase activity; a polynucleotide encoding the protein; a microorganism, which comprises the protein, the polynucleotide encoding the protein, or a vector comprising the polynucleotide; and a method of producing polyhydroxyalkanoate (PHA), comprising a step of culturing the microorganism in a medium.